Model 1 | Model 2 | Model 3 | ||||||
---|---|---|---|---|---|---|---|---|
OR (95% CI) | P value | OR (95% CI) | P value | OR (95% CI) | P value | |||
NAFLD | ||||||||
NRI | 1.095 (1.083, 1.108) | < 0.001 | 1.107 (1.092, 1.122) | < 0.001 | 1.099 (1.080, 1.118) | < 0.001 | ||
NRI per IQR | 4.176 (3.489, 4.998) | < 0.001 | 4.913 (3.961, 6.094) | < 0.001 | 4.383 (3.357, 5.723) | < 0.001 | ||
Quartiles of NRI | ||||||||
Q1 | Ref | Ref | Ref | |||||
Q2 | 3.647 (2.241, 5.934) | < 0.001 | 3.960 (1.935, 8.106) | 0.006 | 3.978 (3.500, 4.398) | 0.111 | ||
Q3 | 9.279 (5.816, 14.805) | < 0.001 | 10.484 (5.280, 20.817) | < 0.001 | 9.941 (9.503, 10.379) | 0.062 | ||
Q4 | 23.084 (14.919,35.717) | < 0.001 | 31.869 (16.112, 63.034) | < 0.001 | 25.911 (25.451, 26.372) | 0.046 | ||
P for trend | < 0.001 | < 0.001 | < 0.001 | |||||
Liver fibrosis | ||||||||
NRI | 1.068 (1.042, 1.095) | < 0.001 | 1.087 (1.057, 1.118) | < 0.001 | 1.081 (1.037, 1.126) | 0.009 | ||
NRI per IQR | 2.829 (1.922, 4.165) | < 0.001 | 3.705 (2.388, 5.747) | < 0.001 | 3.375 (1.768, 6.443) | 0.009 | ||
Quartiles of NRI | ||||||||
Q1 | Ref | Ref | Ref | |||||
Q2 | 1.994 (0.625, 6.361) | 0.219 | 2.587 (0.561, 11.929) | 0.159 | 3.180 (1.999, 4.361) | 0.306 | ||
Q3 | 1.428 (0.383, 5.334) | 0.566 | 2.174 (0.382, 12.390) | 0.283 | 2.183 (0.842, 3.524) | 0.458 | ||
Q4 | 7.014 (2.251, 21.851) | 0.003 | 12.924 (3.212, 52.008) | 0.007 | 11.325 (10.100, 12.549) | 0.160 | ||
P for trend | 0.002 | 0.003 | 0.027 |